Article Sidebar
Published:
May 9, 2025Keywords:
Article Details
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Clinical analysis of dexmedetomidine-esketamine combined with intranasal administration before laparoscopic high ligation of hernia sac in infants and young children
Abstract
Background: Studying To investigate the clinical values of dexmedetomidine and esketamine combined with intranasal infusion before laparoscopic high ligation of hernia sacs in infants and young children.
Methodology: In our hospital, 90Ninety children aged 8-14 years underwent surgical high ligation of the hernia sac between March 2021 and March 2022 were included. During March 2021 to March 2022, 90 children aged 8-14 underwent surgical high ligation of hernia sacs at our hospital. The study and control groups were divided. Each group had 45 cases. A routine fast was given to all the children before anesthesia, and they received midazolam for the contrast set and dexmedetomidine combined with esketamine for the examination set. The onset time, recovery time, sedation time and other indicators were analyzed.
Results: The onset time of sedation in the study group was significantly lower than that in the control group, and the sedation time was significantly higher than that in the control group(P<0.05). The Ramsay score of the study group was significantly higher than that of the control group, and the difference was statistically significant (P<0.05). After sedation, the Montreal cognitive assessment (MoCA) scores of the study group was significantly lower than the control group (P<0.05). After sedation, the Ramsay score and MoCA score were significantly positively correlated (P<0.05).
Conclusion: The use of Dexmedetomidine combined with esketamine nasal drops in infants and young children undergoing laparoscopic high ligation of hernia sac is an effective and safe sedation technique. It not only improves sedation but also reduces the incidence of adverse reactions. Furthermore, it does not impair the cognitive function of children.The combination of dexmedetomidine with esketamine intranasal instillation can improve sedation, reduce adverse reactions, and will not harm them. Clinical efficacy, safety, and cognitive function are high in children.
Keywords: Dexmedetomidine; esketamine; intranasal sedation; infants and young children; high ligation of laparoscopic hernia sac.
